🔍

LENSKART - Lenskart Solut.

📊 NSE: LENSKART 🏢 Speciality Retail 📅 Last Updated: 11/13/2025 15:25

📢 Recent Corporate Announcements

Lenskart Submits SEBI Regulation 74(5) Compliance Certificate for Q4 FY26

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 15 Apr 2026, 12:52 PM

Lenskart Solutions Limited has filed its quarterly compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2026. The certificate, issued by Registrar and Share Transfer Agent MUFG Intime India Private Limited, confirms that all share certificates received for dematerialization were processed and listed on the exchanges. It further verifies that physical certificates were mutilated and cancelled after due verification. This is a standard procedural filing to ensure the integrity of the company's share register.

Compliance certificate submitted for the quarter ended March 31, 2026.
MUFG Intime India Private Limited acted as the Registrar and Share Transfer Agent.
Confirmation that dematerialized securities are listed on the relevant stock exchanges.
Physical security certificates were mutilated and cancelled within prescribed timelines.

💡 No action is required as this is a routine regulatory filing. Investors should focus on the company's upcoming financial results for material performance indicators.

Lenskart Reports Share Capital Reconciliation; Allots 15.45 Lakh ESOP Shares in Q4 FY26

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 14 Apr 2026, 11:43 AM

Lenskart Solutions Limited has filed its quarterly reconciliation of share capital audit report for the period ending March 31, 2026. The company's total issued and listed capital stands at 173.64 crore equity shares with a face value of Rs. 2 each. During the quarter, the company expanded its share base by alloting 15,45,820 equity shares to employees under its 2021 ESOP plan. The report confirms that 100% of the company's shares are held in dematerialized form, ensuring high liquidity and regulatory compliance.

Total issued and listed capital reached 1,73,64,16,007 equity shares as of March 31, 2026
Allotted 15,45,820 equity shares during the quarter following ESOP exercises approved on February 19, 2026
Maintained 100% dematerialization status with 98.13% held in NSDL and 1.87% in CDSL
Confirmed zero pending dematerialization requests beyond the regulatory 21-day limit

💡 This is a routine regulatory filing confirming the company's share capital structure and compliance. No immediate action is required as the ESOP-linked dilution is minimal.

Lenskart to Close Trading Window from April 1, 2026, for Q4 and FY26 Financial Results

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 26 Mar 2026, 05:40 PM

Lenskart Solutions Limited has announced the closure of its trading window starting April 1, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations. This closure is a standard procedure ahead of the declaration of the audited standalone and consolidated financial results for the quarter and financial year ending March 31, 2026. The window will remain closed for all designated persons and insiders until 48 hours after the results are made public. The specific date for the board meeting to approve these results will be announced later.

Trading window closure effective from Wednesday, April 1, 2026.
Closure covers the audited financial results for the quarter and full year ending March 31, 2026.
Window to reopen 48 hours after the official declaration of financial results.
Applies to all Designated Persons, their immediate relatives, and other insiders of the company.

💡 This is a routine regulatory filing and requires no immediate action from investors. Monitor future announcements for the specific date of the board meeting to review the company's annual performance.

Lenskart Shareholders Approve ESOP 2021 & 2025 Amendments with Over 93% Majority

🟢 POSITIVE ⭐ 6/10

MANAGEMENT 📅 23 Mar 2026, 11:38 PM

Lenskart Solutions Limited has successfully passed four special resolutions via postal ballot, focusing on its 2021 and 2025 Employee Stock Option Plans (ESOP). Shareholders approved amendments to align these plans with SEBI regulations and extended grant eligibility to employees of subsidiaries and associate companies globally. The voting process saw a high participation rate of 81.69%, with all resolutions receiving more than 93% approval. These approvals facilitate the company's strategy for talent retention and incentive alignment across its global group structure.

Shareholders approved amendments to ESOP 2021 and ESOP 2025 to comply with SEBI Share Based Employee Benefit regulations.
Extended ESOP grant eligibility to employees of group companies, subsidiaries, and associates both in India and internationally.
Total votes polled reached 1,41,71,56,399, representing a significant 81.69% of the total outstanding shares.
Resolutions for plan amendments (1 & 3) received 95.12% approval, while extension resolutions (2 & 4) received 93.50% approval.

💡 Investors should view this as a positive step for talent management, though they should account for eventual equity dilution from these stock options. No immediate action is required, but tracking the scale of future grants in upcoming filings is advised.

Lenskart Schedules Series of Investor and Analyst Meetings in March 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 10 Mar 2026, 03:26 PM

Lenskart Solutions Limited has announced a schedule of four group meetings with analysts and institutional investors between March 13 and March 20, 2026. These in-person meetings are slated to take place in Bhiwadi and Gurugram. The company has explicitly stated that no unpublished price sensitive information (UPSI) will be shared during these interactions. This disclosure is a routine compliance filing under Regulation 30 of the SEBI (LODR) Regulations, 2015.

Four group meetings scheduled with analysts and investors in March 2026
In-person meetings to be held at Bhiwadi on March 13, 17, and 20
One in-person meeting scheduled in Gurugram on March 19, 2026
Company confirms no unpublished price sensitive information will be shared
Filing made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations

💡 This is a routine regulatory update; investors should monitor the company's website for any post-meeting presentations or transcripts that may provide qualitative insights into business operations.

Lenskart Allots 15.45 Lakh Equity Shares Under ESOP 2021

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 19 Feb 2026, 05:39 PM

Lenskart Solutions Limited has approved the allotment of 1,545,820 equity shares to employees under its 2021 ESOP scheme. The shares have a face value of ₹2 each and were issued at exercise prices ranging from ₹4.12 to ₹183.9 per share. This allotment increases the company's total paid-up equity share capital to approximately ₹347.28 crore. The dilution to existing shareholders is minimal, representing less than 0.1% of the total share capital.

Allotment of 1,545,820 equity shares of ₹2 face value each upon exercise of vested options.
Exercise price for the options ranged between ₹4.12 and ₹183.9 per share.
Total paid-up share capital increased from 1,734,870,187 to 1,736,416,007 equity shares.
The new shares rank pari passu with existing equity shares and have no lock-in period.

💡 This is a routine exercise of employee stock options with negligible dilution. No immediate action is required from investors.

Lenskart Seeks Shareholder Approval for ESOP 2021 and 2025 Plan Amendments

🟡 NEUTRAL ⭐ 6/10

MANAGEMENT 📅 17 Feb 2026, 10:26 PM

Lenskart Solutions Limited has issued a postal ballot notice to seek shareholder approval for four special resolutions concerning its Employee Stock Option Plans (ESOP). The company intends to amend and ratify the ESOP 2021 and ESOP 2025 schemes to ensure full compliance with SEBI (Share Based Employee Benefit and Sweat Equity) Regulations, 2021. Furthermore, the resolutions propose extending these grants to eligible employees of subsidiary and associate companies globally. This administrative step follows the company's listing and is aimed at aligning incentive structures with regulatory requirements for public companies.

Proposed ratification of ESOP Plan 2021 and ESOP Plan 2025 to align with SEBI SBEB Regulations.
Extension of stock option eligibility to employees of group, subsidiary, and associate companies in India and abroad.
Remote e-voting period is set from February 19, 2026, to March 20, 2026, with results by March 23, 2026.
The resolutions are classified as Special Resolutions, requiring a 75% majority for approval.
Equity shares underlying the options have a face value of Rs. 2 per share.

💡 Investors should note that these amendments are standard post-IPO compliance measures to manage employee compensation and retention. While ESOPs lead to minor equity dilution, they are essential for talent management in high-growth retail-tech firms.

Lenskart Schedules Investor Meetings in New York and Mumbai for February 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 13 Feb 2026, 12:16 PM

Lenskart Solutions Limited has announced a series of upcoming meetings with analysts and institutional investors. The schedule includes a group meeting in New York on February 19, 2026, followed by one-on-one and group meetings in Mumbai on February 23 and 24, 2026. These meetings are part of the company's regular investor engagement strategy. The company has clarified that no unpublished price sensitive information (UPSI) will be shared during these interactions.

Group meeting scheduled in New York on February 19, 2026
One-on-one and group meetings in Mumbai on February 23, 2026
Follow-up meetings in Mumbai scheduled for February 24, 2026
Compliance with Regulation 30 of SEBI (LODR) Regulations, 2015
No unpublished price sensitive information to be disclosed

💡 No immediate action is required as this is a routine disclosure. Investors may look for subsequent investor presentations or transcripts on the company's website for updates on business strategy.

Lenskart Releases Audio Recording of Q3 and 9M FY26 Earnings Call

🟡 NEUTRAL ⭐ 3/10

EARNINGS 📅 12 Feb 2026, 12:18 AM

Lenskart Solutions Limited has officially released the audio recording of its earnings conference call held on February 11, 2026. The call focused on the financial performance for the third quarter and the nine-month period ending December 31, 2025. This disclosure follows the requirements of Regulation 30 of the SEBI LODR Regulations. Investors can access the full discussion through the provided link to evaluate management's perspective on recent business developments.

Earnings call for Q3 and 9M FY26 was conducted on February 11, 2026.
Audio recording link provided: https://assets.lenskart.com/audio/2026/02/11/10039855.mp3.
Filing is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Information is also available on the Lenskart investor relations portal for public access.

💡 Investors should review the audio recording to gain qualitative insights into the company's operational performance and future guidance provided by the management. This is a routine compliance update and does not require immediate portfolio adjustments.

Lenskart Q3 FY26: PAT Triples to ₹1,327M, Revenue Up 37.4% with 20% EBITDA Margin

🟢 POSITIVE ⭐ 9/10

EARNINGS 📅 11 Feb 2026, 04:17 PM

Lenskart reported a robust Q3 FY26 with revenue growing 37.4% YoY, driven by strong volume expansion and new customer additions. Profitability saw a massive jump as EBITDA grew 90.6% YoY, with margins expanding from 14.5% to 20.0% due to structural operating leverage. Net profit (PAT) tripled to ₹1,327 million for the quarter, while the company added 195 net new stores globally. The international segment is scaling rapidly, achieving a 6.1% EBITDA margin (pre-IndAS 116) in 9M FY26, significantly outpacing India's historical profitability curve at a similar scale.

Revenue grew 37.4% YoY in Q3 FY26, with India growing 40.4% and International 32.7%.
EBITDA margins expanded to 20.0% from 14.5% YoY, resulting in a 1.9x growth in EBITDA.
PAT for Q3 FY26 reached ₹1,327 million, a 3.4x increase compared to ₹393 million in Q3 FY25.
India delivered record Same-Store Sales Growth (SSSG) of 27.8% and Same Pincode Sales Growth (SPSG) of 35.8%.
Conducted 6.3 million eye tests in Q3 (+54% YoY), with 49% being first-time exams, effectively expanding the addressable market.

💡 Investors should monitor the company's successful 'House of Brands' strategy and its ability to maintain high SSSG despite aggressive store densification. The rapid margin expansion in international markets like Japan and Singapore suggests a scalable and increasingly profitable global model.

Lenskart Approves ESOP Plans for 3.33 Crore Shares and Subsidiary Loan-to-Equity Conversion

🟢 POSITIVE ⭐ 7/10

BOARD_MEETING 📅 11 Feb 2026, 03:49 PM

Lenskart's board has ratified the 2021 ESOP plan involving 2.6 crore options and approved a new 2025 ESOP plan for 72.8 lakh options. The 2025 plan will primarily utilize secondary market acquisitions via a trust route, which helps limit fresh equity dilution for existing shareholders. Additionally, the company is converting existing inter-company loans into equity for its key overseas subsidiaries, Lenskart Singapore and NESO Brands. These measures are designed to align global employee interests and strengthen the balance sheets of international units.

Ratified ESOP Plan 2021 covering 2,60,40,528 options through fresh allotment (Direct Route)
Approved ESOP Plan 2025 for 7,280,431 options with secondary market acquisition as the primary mode
Exercise price for both plans set at 30-day average closing price with a maximum 25% discount
Authorized conversion of pre-existing inter-company loans to equity in Lenskart Singapore Pte. Ltd. and NESO Brands Pte. Ltd.
ESOP benefits extended to employees of all group companies, subsidiaries, and associates globally

💡 Investors should view the secondary acquisition route for the 2025 ESOP plan as a positive step to prevent dilution, while monitoring the performance of overseas subsidiaries following the capital restructuring.

Lenskart Board Approves ESOP Plans for 33M+ Shares and Subsidiary Loan-to-Equity Conversion

🟡 NEUTRAL ⭐ 7/10

BOARD_MEETING 📅 11 Feb 2026, 03:48 PM

Lenskart Solutions Limited has ratified two major Employee Stock Option Plans, ESOP 2021 and ESOP 2025, covering a total of 33,320,959 options. ESOP 2021 involves the fresh allotment of 26,040,528 shares, while ESOP 2025 covers 7,280,431 shares primarily through secondary market acquisition via a Trust route. Furthermore, the board approved converting existing inter-company loans into equity for its overseas subsidiaries, Lenskart Singapore Pte. Ltd. and NESO Brands Pte. Ltd. These measures are designed to enhance talent retention across global operations and optimize the capital structure of international units.

Ratified ESOP Plan 2021 involving 26,040,528 options of face value Rs. 2 each through direct fresh allotment.
Approved ESOP Plan 2025 for 7,280,431 options with secondary market acquisition as the primary mode via a Trust.
Exercise price for options set at 30-day average closing price with a maximum allowable discount of 25%.
Authorized conversion of pre-existing inter-company loans to equity in Lenskart Singapore Pte. Ltd. and NESO Brands Pte. Ltd.
ESOP benefits extended to employees of all group companies, subsidiaries, and associates in India and abroad.

💡 Investors should note the potential equity dilution from the 26 million shares under ESOP 2021, while the loan conversion indicates a strengthening of the balance sheets for key overseas subsidiaries.

Lenskart Approves ESOP Plans for 3.33 Crore Shares and Subsidiary Loan-to-Equity Conversion

🟢 POSITIVE ⭐ 7/10

BOARD_MEETING 📅 11 Feb 2026, 03:46 PM

Lenskart Solutions Limited has ratified two major Employee Stock Option Plans, ESOP 2021 and ESOP 2025, covering a total of approximately 3.33 crore equity shares. ESOP 2021 involves 2.60 crore options via fresh allotment, while ESOP 2025 involves 72.8 lakh options primarily through secondary market acquisition to minimize dilution. The board also approved converting existing inter-company loans into equity for its overseas subsidiaries, Lenskart Singapore Pte. Ltd. and NESO Brands Pte. Ltd. These moves aim to strengthen talent retention across global operations and optimize the capital structure of international units.

Ratification of ESOP 2021 covering 2,60,40,528 options via direct fresh allotment of shares
Approval of ESOP 2025 for 7,280,431 options with secondary market acquisition as the primary implementation mode
Exercise price for both plans set at 30-day average closing price with a maximum permissible discount of 25%
Conversion of pre-existing inter-company loans to equity in wholly owned subsidiaries Lenskart Singapore and NESO Brands
Extension of ESOP benefits to employees of all group companies, subsidiaries, and associates globally

💡 Investors should note the potential equity dilution from ESOP 2021 fresh allotments, though the use of secondary acquisitions for ESOP 2025 mitigates this risk. The loan-to-equity conversion in Singapore subsidiaries indicates a long-term commitment to strengthening international balance sheets.

Lenskart Q3 FY26 Revenue Surges 38% YoY to ₹23,077 Million; Growth Momentum Continues

🟢 POSITIVE ⭐ 8/10

EARNINGS 📅 11 Feb 2026, 03:34 PM

Lenskart Solutions Limited reported a robust performance for the quarter ended December 31, 2025, with revenue from operations reaching ₹23,077.31 million, a 38.3% increase from ₹16,688.35 million in the same quarter last year. For the nine-month period, revenue stood at ₹62,983.31 million, up from ₹49,249.48 million in the previous year. While employee benefit expenses rose significantly to ₹5,277.87 million, the company maintained a positive gap between total income (₹23,480.95 million) and total expenses (₹21,626.41 million). The results reflect the successful integration of recent global acquisitions and expansion across its 23 subsidiaries.

Quarterly revenue from operations grew 38.3% YoY to ₹23,077.31 million.
Nine-month revenue for FY26 reached ₹62,983.31 million, showing strong 27.9% growth over 9M FY25.
Employee benefit expenses increased to ₹5,277.87 million from ₹3,251.06 million YoY, indicating aggressive hiring and scale.
Total income for Q3 FY26 stood at ₹23,480.95 million against total expenses of ₹21,626.41 million.
Consolidated results now include impact from new acquisitions like Stellio Ventures and Quantduo Technologies.

💡 Investors should view the strong revenue growth as a sign of successful market penetration and scale. Monitor the rising employee and operational costs to ensure that margins are not compromised during this high-growth phase.

Lenskart Schedules Q3 & 9M FY26 Earnings Call for February 11, 2026

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 04 Feb 2026, 03:13 PM

Lenskart Solutions Limited has announced its earnings conference call scheduled for Wednesday, February 11, 2026, at 05:30 PM IST. The call is intended to discuss the company's financial results for the third quarter and the nine-month period ended December 31, 2025. This specific filing provides a corrected registration link for analysts and institutional investors to participate. Pre-registration is mandatory for all participants via the provided Chorus Call platform link.

Earnings call scheduled for February 11, 2026, at 05:30 PM IST
Focus on financial results for the quarter and nine months ended December 31, 2025
Mandatory pre-registration required via the provided digital link
This update provides a corrected joining link for the previously announced schedule
Management will provide commentary and host a Q&A session for institutional investors

💡 Interested investors should use the updated link to register for the call to gain insights into the company's Q3 performance. No immediate action is required as this is a routine administrative update.

View All LENSKART Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

India business grew 24.7% YoY in H1 FY26. International business grew 26.1% YoY on a pro-forma basis in H1 FY26. Total pro-forma revenue for Q2 FY26 was INR 21,466 million, up 24% YoY.

Geographic Revenue Split

India remains the primary market with 24.7% growth; International markets (Singapore, UAE, Saudi Arabia, Japan, Thailand) contributed 26.1% growth. Singapore and UAE are established leaders, while Japan and Thailand are in scaling phases.

Profitability Margins

Product margins improved to 69.2% in Q2 FY26 from 64% in FY23 due to vertical integration. PAT margin for Q2 FY26 stood at 5.3% (INR 1,130 million), up from 4.4% YoY. H1 FY26 PAT margin was 4.6% (INR 1,937 million).

EBITDA Margin

Consolidated EBITDA margin reached 19.8% in Q2 FY26 (INR 4,258 million), up from 18.3% YoY. India EBITDA margin was 19.5% in H1 FY26, while International EBITDA margin was 18.2%.

Capital Expenditure

Significant investments in a new Hyderabad manufacturing plant and the Bhiwadi lens factory to drive backward integration. Specific INR Cr values for total planned CAPEX were not disclosed in the documents.

⚙️ Operational Drivers

Raw Materials

Frames (acetate, metal) and Lenses (CR-39, polycarbonate). Vertical integration provides a 35% to 40% cost advantage over competitors.

Import Sources

Transitioning from imports to domestic manufacturing in India (Bhiwadi and Hyderabad). International markets like Japan (Tokai lenses) and Germany (Rodenstock) provide technology and premium components.

Key Suppliers

Internal manufacturing units (Bhiwadi for lenses, Hyderabad for frames); Licensed partnerships with Rodenstock (Germany) and Tokai (Japan).

Capacity Expansion

In-house frame manufacturing scaled from 4.4 million frames/year in FY23 to approximately 4 million frames in H1 FY26 alone. Targeting over 450 net new store additions in India for full year FY26.

Raw Material Costs

Product margins of 69.2% imply raw material and direct manufacturing costs are approximately 30.8% of revenue. Shifting manufacturing to India is expected to save 20% to 25% on costs.

Manufacturing Efficiency

Vertical integration and centralization drive a 35-40% cost advantage; Kaizen processes implemented daily to find efficiencies in packaging and engineering.

Logistics & Distribution

Proprietary logistics system offers 50% money back if next-day delivery is missed, ensuring high reliability and brand trust.

📈 Strategic Growth

Expected Growth Rate

20-26%

Growth Strategy

Achieved through vertical integration (69.2% margins), aggressive store expansion (>450 stores in FY26), and market densification using GeoIQ analytics. International scaling in Japan and Thailand and premiumization through the Meller brand (higher margins) are key drivers.

Products & Services

Prescription eyeglasses, sunglasses, contact lenses, blue-block lenses, and comprehensive eye-testing services (9.3 million tests conducted in H1 FY26).

Brand Portfolio

Lenskart, Owndays, Meller, Rodenstock (licensed), Tokai (licensed), Dealskart.

New Products/Services

Premium brand Meller and neuroscience-based Tokai lenses; AI virtual try-on features driving 45% digitally influenced sales.

Market Expansion

Targeting 2,000 new towns in India; expanding footprint in Saudi Arabia, Thailand, and Japan to replicate the Singapore market leadership model.

Market Share & Ranking

Less than 5% market share in India (estimated $9.2 billion market); Largest eyewear player in Singapore (1 in 4 people wear Lenskart).

Strategic Alliances

Partnerships with Rodenstock for German lens technology and Tokai for Japanese neuroscience lenses; acquisition of Meller for premium segment entry.

🌍 External Factors

Industry Trends

Shift from unorganized to organized retail; increasing myopia rates globally; technology-led omnichannel adoption (45% digital influence). Lenskart is positioned as a vertically integrated cost leader.

Competitive Landscape

Competes with local unorganized opticians and global players like Owndays (now part of the group); focuses on NPS and quality rather than direct price wars.

Competitive Moat

Durable moat through vertical integration (40% cost advantage), high Net Promoter Score (79), and proprietary tech (GeoIQ). Sustainability is driven by the 'compounding flywheel' where growth fuels further cost efficiencies.

Macro Economic Sensitivity

High sensitivity to consumer discretionary spending; 60% myopia rate in India and 80% in SE Asia drive structural demand.

Consumer Behavior

60% of customers prioritize quality followed by style; increasing demand for neighborhood accessibility and next-day delivery.

Geopolitical Risks

Trade barriers affecting lens imports, mitigated by shifting manufacturing to Bhiwadi and Hyderabad.

⚖️ Regulatory & Governance

Industry Regulations

Compliance with SEBI (LODR) Regulations 2015 and SEBI (Depositories and Participants) Regulations 2018 following listing.

Taxation Policy Impact

Subject to standard corporate tax; GST impact noted in Q2 FY26 financials for the month of September.

⚠️ Risk Analysis

Key Uncertainties

Integration risks of new acquisitions (Meller, GeoIQ); execution risk in high-growth markets like Saudi Arabia; potential quality issues (e.g., blue-block lens feedback).